Virginia Retirement Systems Et Al Arbutus Biopharma Corp Transaction History
Virginia Retirement Systems Et Al
- $15 Billion
- Q3 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 21,200 shares of ABUS stock, worth $96,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,200
Previous 36,300
41.6%
Holding current value
$96,460
Previous $112,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ABUS
# of Institutions
184Shares Held
118MCall Options Held
1MPut Options Held
478K-
Morgan Stanley New York, NY24.2MShares$110 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$60.7 Million14.31% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$52.6 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$47.5 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$41.3 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $682M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...